BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Adams SV, Ahnen DJ, Baron JA, Campbell PT, Gallinger S, Grady WM, LeMarchand L, Lindor NM, Potter JD, Newcomb PA. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. World J Gastroenterol 2013; 19(21): 3241-3248 [PMID: 23745025 DOI: 10.3748/wjg.v19.i21.3241]
URL: https://www.wjgnet.com/1007-9327/full/v19/i21/3241.htm
Number Citing Articles
1
Rajeev K. Salunke, Murali Dharan, John W. Birk. Inflammatory Bowel DiseaseClinical Gastroenterology 2021; : 265 doi: 10.1007/978-3-030-81780-0_11
2
Pierre Fwelo, Oladipo Afolayan, Kenechukwu O.S. Nwosu, Akpevwe A. Ojaruega, Onyekachi Ahaiwe, Olajumoke A. Olateju, Ogochukwu Juliet Ezeigwe, Toluwani E. Adekunle, Ayrton Bangolo. Racial and ethnic differences in colon cancer surgery type performed and delayed treatment among people 45 years old and older in the USA between 2007 and 2017: Mediating effect on survivalSurgical Oncology 2023; 50: 101983 doi: 10.1016/j.suronc.2023.101983
3
Azah A Althumairi, Mark G Lazarev, Susan L Gearhart. Inflammatory bowel disease associated neoplasia: A surgeon’s perspectiveWorld Journal of Gastroenterology 2016; 22(3): 961-973 doi: 10.3748/wjg.v22.i3.961
4
Massimo Claudio Fantini, Ilaria Guadagni. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapiesDigestive and Liver Disease 2021; 53(5): 558 doi: 10.1016/j.dld.2021.01.012
5
Christof Kaltenmeier, Chengli Shen, David S. Medich, David A. Geller, David L. Bartlett, Allan Tsung, Samer Tohme. Time to Surgery and Colon Cancer Survival in the United StatesAnnals of Surgery 2021; 274(6): 1025 doi: 10.1097/SLA.0000000000003745
6
Luca Roncucci, Francesco Mariani. Prevention of colorectal cancer: How many tools do we have in our basket?European Journal of Internal Medicine 2015; 26(10): 752 doi: 10.1016/j.ejim.2015.08.019
7
Jörn Gröne. Moderne Chirurgie des Rektumkarzinoms2015; : 121 doi: 10.1007/978-3-642-40390-3_12
8
Sabrina Jeppsson, Shanthi Srinivasan, Bindu Chandrasekharan. Neuropeptide Y (NPY) promotes inflammation-induced tumorigenesis by enhancing epithelial cell proliferationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(2): G103 doi: 10.1152/ajpgi.00410.2015
9
Alan Askari, Luis Sánchez Guillén, Monica Millan, Subramanian Nachiappan, Alex Bottle, Thanos Athanasiou, Omar Faiz. Colorectal tumour characteristics and oncological outcome in patients with inflammatory bowel diseaseSurgical Practice 2020; 24(2): 60 doi: 10.1111/1744-1633.12421
10
Mark A. Jenkins, Aung K. Win, Noralane M. Lindor. Hereditary Colorectal Cancer2018; : 427 doi: 10.1007/978-3-319-74259-5_27
11
Christopher C. Taylor, Valentine O. Millien, Jason K. Hou, Nader N. Massarweh. Association Between Inflammatory Bowel Disease and Colorectal Cancer Stage of Disease and SurvivalJournal of Surgical Research 2020; 247: 77 doi: 10.1016/j.jss.2019.10.040
12
Hadis Najafimehr, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Hamid Mohaghegh Shalmani, Amir Vahedian-Azimi, Matthew Kroh, Mohammad Reza Zali, Amirhossein Sahebkar, Muhammad Naeem. A Systematic Review and Meta-Analysis on the Association between Inflammatory Bowel Disease Family History and Colorectal CancerGastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/4874459
13
Carol J. Díaz-Díaz, Sean M. Ronnekleiv-Kelly, Manabu Nukaya, Peter G. Geiger, Silvia Balbo, Romel Dator, Bryant W. Megna, Patrick R. Carney, Christopher A. Bradfield, Gregory D. Kennedy. The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in MouseAnnals of Surgery 2016; 264(3): 429 doi: 10.1097/SLA.0000000000001874
14
Mitchell Ramsey, Somashekar G Krishna, Peter P Stanich, Syed Husain, Edward J Levine, Darwin Conwell, Alice Hinton, Cheng Zhang. Inflammatory Bowel Disease Adversely Impacts Colorectal Cancer Surgery Short-term Outcomes and Health-Care Resource UtilizationClinical and Translational Gastroenterology 2017; 8(11): e127 doi: 10.1038/ctg.2017.54
15
László Herszényi, Loránd Barabás, Pál Miheller, Zsolt Tulassay. Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the RiskDigestive Diseases 2015; 33(1): 52 doi: 10.1159/000368447
16
Ramzi Amri, Liliana G. Bordeianou, Patricia Sylla, David L. Berger. Treatment Delay in Surgically-Treated Colon Cancer: Does It Affect Outcomes?Annals of Surgical Oncology 2014; 21(12): 3909 doi: 10.1245/s10434-014-3800-9
17
Baochi Ou, Jingkun Zhao, Shaopei Guan, Aiguo Lu. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-AnalysisDigestive Diseases and Sciences 2016; 61(3): 881 doi: 10.1007/s10620-015-3940-1
18
Georgios Antonios Margonis, Stefan Buettner, Nikolaos Andreatos, Doris Wagner, Kazunari Sasaki, Boris Galjart, Carsten Kamphues, Timothy M Pawlik, George Poultsides, Klaus Kaczirek, Per Eystein Lønning, Cornelis Verhoef, Martin E Kreis, Christopher L Wolfgang, Matthew J. Weiss. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysisJournal of Surgical Oncology 2018; 118(7): 1074 doi: 10.1002/jso.25251
19
Jingyue Zhang, Chaoyue Chen, Wei Yan, Yu Fu. New sights of immunometabolism and agent progress in colitis associated colorectal cancerFrontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1303913
20
Can Lu, Josefine Schardey, Tao Zhang, Alexander Crispin, Ulrich Wirth, Konrad W. Karcz, Alexandr V. Bazhin, Joachim Andrassy, Jens Werner, Florian Kühn. Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated Colorectal CancerAnnals of Surgery 2022; 276(5): e319 doi: 10.1097/SLA.0000000000005339
21
Yuhang Wang, Joyce Z. Gao, Taylor Sakaguchi, Thorsten Maretzky, Prajwal Gurung, Nandakumar S. Narayanan, Sarah Short, Yiqin Xiong, Zizhen Kang. LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut InflammationCells 2024; 13(7): 565 doi: 10.3390/cells13070565